Remus Pharmaceuticals Limited (NSE:REMUS)
India flag India · Delayed Price · Currency is INR
820.55
-20.95 (-2.49%)
At close: Sep 12, 2025

Remus Pharmaceuticals Company Description

Remus Pharmaceuticals Limited engages in the marketing, trading, and distribution of pharmaceutical finished formulations and products in India and internationally.

It is involved in trading of active pharmaceutical ingredient, as well as provides technical consultancy services to various distributors and contract manufacturing services.

The company offers capsule, cream, eye drop, gel, infusion, inhalation, inhaler, injection, nail lacquer, nasal solution, nasal spray, nebulizer, ointment, ophthalmic, oral gel, oral solution, oral suspension, sachet, suspension, and tablets.

It has operations in Bhutan, Bolivia, Chile, Costa Rica, Cuba, the Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Jamaica, Kuwait, Madagascar, Malaysia, Hong Kong, Myanmar, Panama, Trinidad and Tobago, Uzbekistan, Venezuela, and Vietnam.

The company was formerly known as Remus Pharmaceuticals Private Limited and changed its name to Remus Pharmaceuticals Limited in January 2023.

Remus Pharmaceuticals Limited was incorporated in 2015 and is based in Ahmedabad, India.

Remus Pharmaceuticals Limited
CountryIndia
Founded2015
IndustryDrugs, Drug Proprietaries, and Druggists' Sundries
Employees48
CEOArpit Shah

Contact Details

Address:
1101 to 1103, South Tower
Ahmedabad, Gujarat 380054
India
Phone91 79 2999 9857
Websiteremuspharma.com

Stock Details

Ticker SymbolREMUS
ExchangeNational Stock Exchange of India
Fiscal YearApril - March
Reporting CurrencyINR
SIC Code5122

Key Executives

NamePosition
Arpit ShahChief Executive Officer
Anjali ShahChief Financial Officer